Brineura TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: inert substance, cerliponase alfa
Pack: Brineura (2 x 5 mL vials, 1 x 5 mL inert solution vial), 1 pack
Brand name
(ARTG)
: BRINEURA cerliponase alfa (rch) 150 mg/5 mL solution for injection vial with flushing solution vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Brineura is indicated for the treatment of neuronal ceroid lipofuscinosis type 2 (CLN2) disease, also known as tripeptidyl peptidase 1 (TPP1) deficiency.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, solution
- Intracerebroventricular
- Clear, colourless liquid, essentially particle free
Component :
- Injection, solution
- Intracerebroventricular
- Clear to slightly opalescent and colourless to pale yellow solution, that may occasionally contain thin translucent fibres or opaque particles.
Storage conditions
(ARTG)
- Store at minus 20 plus or minus 5 degrees Celsius (deep freeze)
- Protect from Light
- Store Upright
- Store in Original Container
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 2 vials of cerliponase alfa solution and 1 vial of flushing solution pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient cerliponase alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
